Concepedia

Author

Wolfgang Knauf

Praxis für Hämatologie und Onkologie

Also Known As

Knauf W., Knauf, W., Knauf, W. U., Mathias Hänel, T. Fietz, W KNAUF, W Knauf, W U Knauf, W. Knauf, W. U. Knauf

223

Publications

4.7K

Citations

34

H-Index

80

Concepts

All Affiliations

Praxis für Hämatologie und OnkologieFreie Universität BerlinHeidelberg UniversityCharité - Universitätsmedizin BerlinFranklin University
WK

About

Wolfgang Knauf is an author at Praxis für Hämatologie und Onkologie specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

34

1.4K

2

Health Sciences

13

14

502

3

Blood Transplantation

5

5

211

4

Public Health

1

1

12

5

Biomedical Engineering

1

1

14

Wolfgang Knauf

×

73

Publications

4.1K

Citations

32

H-Index

YearCitations

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

Michael Herold, Antje Haas, Stefanie Srock,

Journal of Clinical Oncology

2007

503

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Wolfgang Knauf, Toshko Lissichkov, Ali Aldaoud,

Journal of Clinical Oncology

2009

436

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Michael Hallek, Irmgard Langenmayer, Christoph Nerl,

PubMed

1999

236

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

Jochen Casper, Wolfgang Knauf, Thomas Kiefer,

Blood

2003

146

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

Hartmut Goldschmidt, K. Elias, Uta Bertsch,

The Lancet Haematology

2022

142

Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation

Kathrin Rieger, Olga Marinets, Thomas Fietz,

Experimental Hematology

2005

135

Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site.

M Körbling, Rolf Holle, Rainer Haas,

Journal of Clinical Oncology

1990

122

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

Michael Hallek, Barbara Schmitt, Martin Wilhelm,

British Journal of Haematology

2001

122

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase <scp>III</scp> trial

Wolfgang Knauf, Toshko Lissitchkov, Ali Aldaoud,

British Journal of Haematology

2012

107

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

R. Arnold, Gero Massenkeil, Martin Bornhäuser,

Leukemia

2002

107

Page 1